References
1. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et
al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020.
Rhinology. 2020;58(Suppl S29):1-464.
2. Head K, Chong LY, Hopkins C, Philpott C, Schilder AG, Burton MJ.
Short-course oral steroids as an adjunct therapy for chronic
rhinosinusitis. Cochrane Database Syst Rev. 2016;4:CD011992.
3. Head K, Chong LY, Hopkins C, Philpott C, Burton MJ, Schilder AG.
Short-course oral steroids alone for chronic rhinosinusitis. Cochrane
Database Syst Rev. 2016;4:CD011991.
4. Price D, Castro M, Bourdin A, Fucile S, Altman P. Short-course
systemic corticosteroids in asthma: striking the balance between
efficacy and safety. European respiratory review : an official journal
of the European Respiratory Society. 2020;29(155).
5. Hopkins C, Slack R, Lund V, Brown P, Copley L, Browne J. Long-term
outcomes from the English national comparative audit of surgery for
nasal polyposis and chronic rhinosinusitis. Laryngoscope.
2009;119(12):2459-65.
6. Hopkins C, Browne JP, Slack R, Lund VJ, Topham J, Reeves BC, et al.
Complications of surgery for nasal polyposis and chronic rhinosinusitis:
the results of a national audit in England and Wales. Laryngoscope.
2006;116(8):1494-9.
7. Kim C, Han J, Wu T, Bachert C, Fokkens W, Hellings P, et al. Role of
Biologics in Chronic Rhinosinusitis With Nasal Polyposis: State of the
Art Review. Otolaryngol Head Neck Surg. 2021;164(1):57-66.
8. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et
al. Executive summary of EPOS 2020 including integrated care pathways.
Rhinology. 2020;58(2):82-111.
9. Fokkens WJ, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J, et
al. EUFOREA consensus on biologics for CRSwNP with or without asthma.
Allergy. 2019;74(12):2312-9.
10. Fitch K BS, Aguilar MD, Burnand B, LaCalle JR. The RAND/UCLA
appropriateness method user’s manual. RAND CORP SANTA MONICA CA;2001.
11. Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR. The
RAND/UCLA appropriateness method user’s manual. RAND CORP SANTA MONICA
CA; 2001.
12. Rudmik L, Beswick DM, Alt JA, Bhattacharyya N, Chester AC, Gray ST,
et al. Appropriateness Criteria for Surgery in the Management of Adult
Recurrent Acute Rhinosinusitis. The Laryngoscope. 2019;129(1):37-44.
13. Amin N, Walker A, Alobid I, Anari S, Bast F, Bhalla RK, et al.
Defining appropriateness criteria for endoscopic sinus surgery in the
management of adult dental implant patients with incidental maxillary
sinus findings on conebeam computed tomography. Clin Otolaryngol. 2020.
14. Hopkins C, Alanin M, Philpott C, Harries P, Whitcroft K, Qureishi A,
et al. Management of new onset loss of sense of smell during the
COVID-19 pandemic - BRS Consensus Guidelines. Clin Otolaryngol.
2021;46(1):16-22.
15. Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, et al.
Efficacy and safety of dupilumab in patients with severe chronic
rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP
SINUS-52): results from two multicentre, randomised, double-blind,
placebo-controlled, parallel-group phase 3 trials. Lancet.
2019;394(10209):1638-50.
16. Gevaert P, Omachi TA, Corren J, Mullol J, Han J, Lee SE, et al.
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase
3 trials. J Allergy Clin Immunol. 2020;146(3):595-605.
17. Bachert C, Sousa AR, Lund VJ, Scadding GK, Gevaert P, Nasser S, et
al. Reduced need for surgery in severe nasal polyposis with mepolizumab:
Randomized trial. J Allergy Clin Immunol. 2017;140(4):1024-31 e14.
18. Scangas GA, Wu AW, Ting JY, Metson R, Walgama E, Shrime MG, et al.
Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for
Chronic Rhinosinusitis With Nasal Polyps. Laryngoscope.
2021;131(1):E26-E33.
19. Tice JA WJ, Synnott P, Kumar V, Adair E, Rind D, et al. Biologic
Therapies for Treatment of Asthma Associated with Type 2 Inflammation.
Inst Clin Econ Rev. 2018;1–132.
20. Hopkins C, Lund V. Does time from previous surgery predict
subsequent treatment failure in Chronic Rhinosinusitis with Nasal
Polyps? Rhinology. 2021(In press).
21. van der Veen J, Seys SF, Timmermans M, Levie P, Jorissen M, Fokkens
WJ, et al. Real-life study showing uncontrolled rhinosinusitis after
sinus surgery in a tertiary referral centre. Allergy. 2017;72(2):282-90.
Legends
Figure 1a Agreed criteria where it was considered appropriate to
consider treatment with a biologic
Figure 1b Agreed criteria where it was considered not to be appropriate
to consider treatment with a biologic